PLA1A Antikörper (Middle Region)
Kurzübersicht für PLA1A Antikörper (Middle Region) (ABIN954159)
Target
Alle PLA1A Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 336-366, Middle Region
-
Spezifität
- This antibody recognizes Human and Mouse PLA1A (Center).
-
Aufreinigung
- Protein A column, followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide between 336~366 amino acids from the Central region of human PLA1A
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- PLA1A (Phospholipase A1 Member A (PLA1A))
-
Andere Bezeichnung
- PLA1A
-
Hintergrund
- Phosphatidylserine-specific phospholipase A1-alpha (PLA1A) acts specifically on phosphatidylserine (PS) and 1-acyl-2-lysophosphatidylserine (lyso-PS) to hydrolyze fatty acids at the sn-1 position of these phospholipids.Synonyms: NMD, PSPLA1, Phospholipase A1 member A
-
Molekulargewicht
- 49715 Da
-
Gen-ID
- 51365
-
NCBI Accession
- NP_001193889
Target
-